Neuropsychological profile of amyloid-positive versus amyloid-negative amnestic Mild Cognitive Impairment

http://hdl.handle.net/10400.12/7688

Utilize este identificador para referenciar este registo.

Nome:	Descrição:	Tamanho:	Formato:
Journal of Neuropsychology (ScoPUS).pdf		240.59 KB	Adobe PDF	Ver/Abrir

Autores

Cardoso, Sandra

Nogueira, Joana

Pereira, Miguel Tábuas

Baldeiras, Inês

Santana, Isabel

Resumo(s)

Patients diagnosed with amnestic mild cognitive impairment (aMCI) are at high risk of progressing to dementia. It became possible, through the use of biomarkers, to diagnose those patients with aMCI who have Alzheimer's disease. However, it is presently unfeasible that all patients undergo biomarker testing. Since neuropsychological testing is required to make a formal diagnosis of aMCI, it would be interesting if it could be used to predict the amyloid status of patients with aMCI.

URI

http://hdl.handle.net/10400.12/7688

Citação

Journal of Neuropsychology Doi: 10.1111/jnp.12218

Projetos de investigação

Beyond Beta-Amyloid - Deciphering Early Pathogenic Changes in Alzheimer's disease

Projeto de investigaçãoVer mais

Editora

Wiley-Blackwell

DOI

10.1111/jnp.12218

Coleções

APPsyCI - Artigos em revistas científicas internacionais

Licença CC

cclicense-by-nc-nd

Métricas Alternativas

Ver registo completo